The association between glutathione S-transferase M1 genotype and polycyclic aromatic hydrocarbon-DNA adducts in breast tissue

Cancer Epidemiology Biomarkers and Prevention

Volumn 9, Issue 10, 2000, Pages 1079-1085

  Rundle, A ^a   Tang, D ^a   Zhou, J ^a   Cho, S ^a   Perera, F ^a  

^a Columbia School of Public Health ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GLUTATHIONE TRANSFERASE; POLYCYCLIC AROMATIC HYDROCARBON;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; DNA ADDUCT; FEMALE; GENE DELETION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADULT; AGED; BREAST; BREAST NEOPLASMS; CASE-CONTROL STUDIES; DNA ADDUCTS; DNA DAMAGE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMAN; MIDDLE AGE; POLYCYCLIC HYDROCARBONS, AROMATIC; POLYMERASE CHAIN REACTION; RISK ASSESSMENT;

EID: 0033789492     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Rising incidence of breast cancer: Relationship to stage and receptor status
2. Breast cancer
3. Proportion of breast cancer cases in the United States explained by well-established risk factors
4. Environmental carcinogens that may be involved in human breast cancer etiology
5. Carcinogen-DNA adducts in human breast tissue
6. The role of aromatic hydrocarbons in the genesis of breast cancer
7. Pesticides and polychlorinated biphenyl residues in human breast lipids and their relation to breast cancer
8. Blood levels of organochlorine residues and risk of breast cancer
9. Cigarette smoking and other risk factors in relation to p53 expression in breast cancer among young women
10. Environment and cancer: Who are susceptible?
11. Aromatic DNA adducts in adjacent tissues of breast cancer patients: Clues to breast cancer etiology
12. Genetic damage in breast tissue from polycyclic aromatic hydrocarbons is associated with breast cancer
13. Glutathione S-transferase MI (GSTM1) deficiency and lung cancer risk
14. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility
15. Associations between both genetic and environmental biomarkers and lung cancer: Evidence of a greater risk of lung cancer in women smokers
16. Glutathione S-transferase class μ deletion polymorphism and breast cancer: Results from prevalent versus incident cases
17. Cytochrome P4501A1 and glutathione S-transferase (M1) genetic polymorphisms and postmenopausal breast cancer risk
18. Allelotype influence at glutathione S-transferase MI locus on breast cancer susceptibility
19. Breast cancer and CYP1A1, GSTM1, and GSTT1 polymorphisms: Evidence of a lack of association in Caucasians and African Americans
20. Glutathione-S-transferase (GSTM1) genetic polymorphisms do not affect human breast cancer risk, regardless of dietary antioxidants
21. Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer
22. Association between glutathione S-transferase M1, P1 and T1 genetic polymorphisms and development of breast cancer
23. Single tube multiplex polymerase chain reaction genotype analysis of GSTM1, GSTT1 and GSTP1: Relation of genotypes to TP53 tumor status and clinicopathological variables in breast cancer patients
24. Genetic risk and carcinogen exposure: A common inherited defect of the carcinogen-metabolism gent glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer
25. Immunohistochemical detection of polycyclic aromatic hydrocarbon-DNA damage in human blood vessels of smokers and non-smokers
26. Evaluation of polycyclic aromatic hydrocarbon-DNA adducts in exfoliated oral cells by an immunohistochemical assay
27. Polycyclic aromatic hydrocarbon-DNA adducts in human placenta and modulation by CYP1A1 induction and genotype
28. Smoking-associated bulky DNA adducts in bronchial tissue related to CYP1A1 MspI and GSTM1 genotypes in lung patients
29. White blood cell DNA adducts, smoking, and NAT2 and GSTM1 genotypes in bladder cancer: A case-control study
30. Impact of inherited polymorphisms in glutathione S-transferase M1, microsomal epoxide hydrolase, cytochrome P450 enzymes on DNA, and blood protein adducts of benzo(a)pyrene-diolepoxide
31. Modulation of DNA adduct levels in human mononuclear white blood ceils and granulocytes by CYP1A1 CYP2D6 and GSTM1 genetic polymorphisms
32. Characterization of CYP1B1 and CYP1A1 expression in human mammary epithelial cells: Role of the aryl hydrocarbon receptor in polycyclic aromatic hydrocarbon metabolism
33. Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells
34. Benzo[a]pyrene metabolism in human T47D mammary tumor cells: Evidence for sulfate conjugation and translocation of reactive metabolites across cell membranes
35. Conjugation of chemical carcinogens by primary cultures of human hepatocytes
36. Main drug-metabolizing enzyme systems in human breast tumors and peritumoral tissues
37. Enzymatic control of estrogen production in human breast cancer: Relative significance of aromatase versus sulfatase pathways
38. Determinants of tissue estradiol levels and biologic responsiveness in breast tumors
39. Control and expression of oestrone sulphatase activities in human breast cancer
40. Steroid sulfotransferases and steroid sulfate sulfatases: Characteristics and biological roles
41. Breast cancer risk associated with proliferative disease, age at first birth, and a family history of breast cancer
42. Epidemiology of benign breast disease, with special attention to histologic types
43. Risk factors for fibrocystic breast disease and its histopathologic components
44. Age at first birth and breast atypia
45. Risk factors relevant to cystic breast disease: A case-control study
46. An epidemiologic study of fibrocystic breast disease with reference to ductal epithelial atypia
47. Immunological methods for detection of carcinogen-DNA damage in humans
48. Derivative fluorescence spectral analysis of polycyclic aromatic hydrocarbon-DNA adducts in human placenta
49. Quantitation of carcinogen-DNA adducts with monoclonal antibodies
50. Detection of benzo(a)pyrene diol epoxide-DNA adducts in sperm of men exposed to cigarette smoke
51. Immunodetection of benzo[a]pyrene adducts in ovarian cells of women exposed to cigarette smoke
52. Detection of benzo[a]pyrene diol epoxide-DNA adducts in embryos from smoking couples: Evidence for transmission by spermatozoa
53. Immunoperoxidase detection of polycyclic aromatic hydrocarbon-DNA adducts in oral mucosa cells of smokers and nonsmokers
54. Immunoperoxidase quantitation of 4-aminobiphenyl- and polycyclic aromatic hydrocarbon-DNA adducts in exfoliated oral and urothelial cells of smokers and nonsmokers
55. Immunohistochemical quantitation of polycyclic aromatic hydrocarbon-DNA adducts in human lymphocytes
56. Polycyclic aromatic hydrocarbon-DNA adducts in cervical smears of smokers and nonsmokers
57. A molecular epidemiology study in women from Upper Silesia, Poland